Jon Paul Newsome

Mark Hughes

Matthew Carletti

Gregory Peters

Robert Farnam

Maxwell Fritscher

Sidney Schultz

- For the three months ended September 30, 2025, ProAssurance reported **net income of $1.4 million, or $0.03 per diluted share**, and **operating income of $7.9 million, or $0.15 per diluted share**.  **[1127703_cc51053b766f4e0b8f12d72e283eff30_0]** 
- Consolidated **net premiums written were $261.3 million** for the third quarter of 2025.  **[1127703_cc51053b766f4e0b8f12d72e283eff30_0]** 
- The consolidated **Non-GAAP combined ratio was 112.2%** in the third quarter of 2025, with the Specialty P&C segment at 109.1%.  **[1127703_cc51053b766f4e0b8f12d72e283eff30_0]** 
- **Book value per share was $25.37** at September 30, 2025, an increase from $23.49 at year-end 2024.  **[1127703_cc51053b766f4e0b8f12d72e283eff30_0]** 
- The transaction with The Doctors Company is currently anticipated to close by **June 30, 2026**, pending regulatory approvals in California, Pennsylvania, and Texas.  **[1127703_cc51053b766f4e0b8f12d72e283eff30_2]**

ProAssurance Reports Third Quarter 2025 Results

- ProAssurance Corporation reported **net income** of **$1.4 million**, or **$0.03 per diluted share**, for the three months ended September 30, 2025.  **[1127703_0001127703-25-000012_pra-20250930xex991xmaster.htm:0]** 
- **Operating income** for the third quarter of 2025 was **$7.9 million**, or **$0.15 per diluted share**.  **[1127703_0001127703-25-000012_pra-20250930xex991xmaster.htm:0]** 
- **Total revenues** for Q3 2025 amounted to **$279.6 million**.  **[1127703_0001127703-25-000012_pra-20250930xex991xmaster.htm:2]** 
- The **consolidated combined ratio** for the quarter ended September 30, 2025, was **114.7%**.  **[1127703_0001127703-25-000012_pra-20250930xex991xmaster.htm:3]** 
- As of September 30, 2025, **shareholders' equity** stood at **$1,304.3 million**, with **book value per share** at **$25.37**.  **[1127703_0001127703-25-000012_pra-20250930xex991xmaster.htm:3]**

PROASSURANCE (PRA)